Coherus BioSciences, Inc. (NASDAQ:CHRS)

CAPS Rating: 3 out of 5

Results 1 - 1 of 1

Recs

0
Member Avatar murphydevani (66.45) Submitted: 8/21/2015 9:08:55 AM : Underperform Start Price: $28.55 CHRS Score: +42.98

Target $27 - $25 - $21

Results 1 - 1 of 1

Featured Broker Partners